Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 2Phase NA 1Phase 4 1Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Advanced Hormone Receptor-Positive Breast Carcinoma 1

Interventions

Specimen Handling 147pembrolizumab 124Magnetic Resonance Spectroscopy 114Cyclophosphamide 114Biopsy 104fludarabine 84Nivolumab 59Carboplatin 54Gemcitabine 46Cisplatin 46venetoclax 45Radiotherapy 45Paclitaxel 43Ipilimumab 38fludarabine phosphate 37Cetuximab 37Fluorouracil 34atezolizumab 31Bevacizumab 31durvalumab 30X-Rays 28Oxaliplatin 28Dexamethasone 28Leucovorin 27Radiation 26Irinotecan 26Azacitidine 25Injections 24Cytarabine 24Radiosurgery 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Clinical Protocols × 90 days × Clear all
NCT07590583 2026-05-15

Biology Guided Therapy Recommendations for Treatment Determination of Hormone Receptor-Positive Advanced, Unresectable or Metastatic Breast Cancer, ENDORSE Trial

City of Hope Medical Center

Phase 1 Not yet recruiting
20 enrolled
Breast

Advanced Hormone Receptor-Positive Breast Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡